Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma.
説明 | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
別名 | SHP-141 |
分子量 | 323.34 |
分子式 | C16H21NO6 |
CAS No. | 946150-57-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (463.91 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Remetinostat 946150-57-8 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC Inhibitor SHP141 SHP-141 inhibit Histone deacetylases SHP 141 inhibitor